Truist Financial began coverage on shares of Guardian Pharmacy Services (NYSE:GRDN – Free Report) in a research report sent to investors on Monday morning, Marketbeat reports. The firm issued a buy rating and a $22.00 price objective on the stock.
Guardian Pharmacy Services Trading Down 1.3 %
Guardian Pharmacy Services stock opened at $17.77 on Monday. Guardian Pharmacy Services has a 12-month low of $14.16 and a 12-month high of $20.10.
Insider Activity at Guardian Pharmacy Services
In related news, Director Thomas J. Salentine, Jr. purchased 35,714 shares of the firm’s stock in a transaction dated Friday, September 27th. The stock was acquired at an average price of $14.00 per share, with a total value of $499,996.00. Following the completion of the transaction, the director now owns 35,714 shares of the company’s stock, valued at $499,996. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website.
Institutional Trading of Guardian Pharmacy Services
About Guardian Pharmacy Services
Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.
Read More
- Five stocks we like better than Guardian Pharmacy Services
- How to Calculate Return on Investment (ROI)
- Chinese Stocks Cool Off: Time to Buy the Dip in These 2 Stocks?
- Best Stocks Under $10.00
- Goldman Sachs Highlights 3 Top Short Squeeze Stocks to Watch
- Why Are Stock Sectors Important to Successful Investing?
- Walmart is Up 56% YTD, Is it Still a Top Consumer Staples Stock?
Receive News & Ratings for Guardian Pharmacy Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Guardian Pharmacy Services and related companies with MarketBeat.com's FREE daily email newsletter.